Literature DB >> 17535087

A case of composite neuroblastoma composed of histologically and biologically distinct clones.

Hideki Sano1, Ignacio Gonzalez-Gomez, Shi Qi Wu, Saro H Armenian, Rima F Jubran, Hiroyuki Shimada.   

Abstract

We report a case of a 12-month-old girl with stage 3 neuroblastoma composed of 2 distinct clones in the adrenal primary tumor. One clone showed neuroblastoma, poorly differentiated subtype with a low mitosis-karyorrhexis index (favorable histology), and the other was neuroblastoma, poorly differentiated subtype with a high mitosis-karyorrhexis index (unfavorable histology), according to the International Neuroblastoma Pathology Classification. Fluorescent-labeled in-situ hybridization using the formalin-fixed, paraffin-embedded material showed that the MYCN oncogene was amplified in the latter clone but not in the former clone. Lymph nodes from ipsilateral and contralateral sides contained metastatic neuroblastoma of the latter clone. It is well documented that tumors in the Ganglioneuroblastoma, nodular (composite, Schwannian stroma-rich/stroma-dominant and stroma-poor) category are composite and composed of multiple clones. To our knowledge, however, this is the 1st case report of composite tumor with biologically favorable and unfavorable clones in the Neuroblastoma (Schwannian stroma-poor) category.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17535087     DOI: 10.2350/06-06-0117.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  2 in total

1.  Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology.

Authors:  Lily Tran; Carrie Fitzpatrick; Susan L Cohn; Peter Pytel
Journal:  Virchows Arch       Date:  2017-09-01       Impact factor: 4.064

2.  Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study.

Authors:  Ana P Berbegall; Dominik Bogen; Ulrike Pötschger; Klaus Beiske; Nick Bown; Valérie Combaret; Raffaella Defferrari; Marta Jeison; Katia Mazzocco; Luigi Varesio; Ales Vicha; Shifra Ash; Victoria Castel; Carole Coze; Ruth Ladenstein; Cormac Owens; Vassilios Papadakis; Ellen Ruud; Gabriele Amann; Angela R Sementa; Samuel Navarro; Peter F Ambros; Rosa Noguera; Inge M Ambros
Journal:  Br J Cancer       Date:  2018-05-14       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.